Assessment of fetal weil-being in methadone-maintained pregnancies: Abnormal nonstress tests

Gynecologic and Obstetric Investigation

Volumn 43, Issue 1, 1997, Pages 25-28

  Anyaegbiinam, A ^a   Tran, T ^a   Jadali, D ^a   Randolph, G ^a   Mikhail, M S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Fetal well being; Methadone maintained pregnancies; Nonstress tests

Indexed keywords

METHADONE;

ADULT; APGAR SCORE; ARTICLE; BIOPHYSICS; BIRTH WEIGHT; BLOOD PH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS HEART RATE; FETUS MONITORING; HEROIN DEPENDENCE; HUMAN; MECONIUM; METHADONE TREATMENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; STRESS; UMBILICAL ARTERY; UNITED STATES; WELLBEING;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANALGESICS, OPIOID; CASE-CONTROL STUDIES; EXERCISE TEST; FEMALE; FETUS; HEART RATE, FETAL; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; METHADONE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES;

EID: 0031022342     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291812     Document Type: Article

References (15)

1. Jaffcc JH, Martin WR: Opioid analgesics and antagonists; in Gilman AG. Rail TW. Nies AS, Taylor P (cds): The Pharmacological Basis of Therapeutics, ed 8. New York, Pergamon Press, 1990, p 485.
2. Wilson GS, Desmond MM, Wait RB: Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: Health, developmental, and social implications. J Pe-diatr 1981:98:716.
3. Salerno LJ: Prenatal care; in Remcntcria JL (ed): Drug Abuse in Pregnancy and Neonatal Effects. St. Louis, Mosby, 1977. p 19.
4. Evertson LR, Gauthier RJ, Schifrin BS, Paul RH: Antepartum fetal heart rate testing: Evolution of the nonstress test. Am J Obstet Gynecol 1979;133:29-33.
5. Lyons ER. Byslma-Howcll M. Sham S. Towcll ME: A scoring system for nonstressed antepartum fetal heart rate monitoring. Am J Obstet Gynecol 1979:133:242-246.
6. Manning FA. Morrison I, Lange IR, Harman CR. Chamberlain PE: Fetal assessment based on fetal biophysical profile scoring: Experience in 12,620 referred high-risk pregnancies. I. Perinatal mortality by frequency and etiology. Am J Obstct Gynecol 1985; 151:343-350.
7. Brennen WE, Edelmen DA. Hendricks CH: A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976:126: 555-564.
8. Hoegcrman G. Sclmoll S: Narcotic use in pregnancy. Clin Perinatol 1991; 18:51.
9. Archie CL, Milton L. Sokol R, Norman G: The effects of methadone treatment on the reactivity of the nonstrcss test. Obstct Gynecol 1989; 74:254-255.
10. Levine A. Rebarber A: Methadone maintenance treatment and the nonstrcss test. J Pcri-natol 1995:15:229-230.
11. Harper R, Solish G, Feingold E. Gerstcnwoolf NB. Sokal MM: Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. Am J Obstct Gynecol 1977; 129:417.
12. Wilson GS, McCreary R, Kean J, Baxter JC: The development of preschool children of heroin-addicted mothers: A controlled study. Pediatrics 1979;63:135.
13. Glass L, Rajegowda BK, Mukherjee TK. Roth MM. Evans HE: Effect of heroin on corticosteroid production in pregnant addicts and their fetuses. Am J Obstet Gynecol 1973; 117:416.
14. Kandall SR. Albin S, Lowinson J. Bcrle B, Eidclntan AI. Gartner LM: Differential effects of maternal heroin and methadone use on birthweight. Pediatrics 1976,58:681.
15. Connaughton JF, Reescr D. Schut J. Finnegan LP: Perinatal addiction: Outcome and management. Am J Obstet Gynecol 1977:129:679.